214 related articles for article (PubMed ID: 20966700)
1. Comparative performance of the 2009 international Federation of gynecology and obstetrics' staging system for uterine corpus cancer.
Lewin SN; Herzog TJ; Barrena Medel NI; Deutsch I; Burke WM; Sun X; Wright JD
Obstet Gynecol; 2010 Nov; 116(5):1141-9. PubMed ID: 20966700
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of the revised international federation of gynecology and obstetrics staging system 2009].
Shen K; Peng P; Wu M
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):721-4. PubMed ID: 21176549
[No Abstract] [Full Text] [Related]
3. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer.
Koskas M; Rouzier R
Obstet Gynecol; 2011 May; 117(5):1225-1226. PubMed ID: 21508766
[No Abstract] [Full Text] [Related]
4. Prognostic factors and risk of extrauterine metastases in 3867 women with grade 1 endometrioid corpus cancer.
Chan JK; Kapp DS; Cheung MK; Shin JY; Stieglitz D; Husain A; Teng NN; Berek JS; Osann K; Guo H
Am J Obstet Gynecol; 2008 Feb; 198(2):216.e1-5. PubMed ID: 18226629
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan.
Kuwabara Y; Susumu N; Banno K; Hirao T; Kawaguchi M; Yamagami W; Suzuki N; Aoki D; Nozawa S
Jpn J Clin Oncol; 2005 Jan; 35(1):23-7. PubMed ID: 15681600
[TBL] [Abstract][Full Text] [Related]
6. [Explanations and discussions of the revised international federation of gynecology and obstetrics staging system 2009].
Shen K; Sun JH; Cao ZY
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):725-31. PubMed ID: 21176550
[No Abstract] [Full Text] [Related]
7. A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer.
Todo Y; Kato H; Minobe S; Okamoto K; Suzuki Y; Konno Y; Takeda M; Watari H; Kaneuchi M; Sakuragi N
Gynecol Oncol; 2011 Apr; 121(1):126-30. PubMed ID: 21194738
[TBL] [Abstract][Full Text] [Related]
8. Juxtatumoral stromal reactions in uterine endometrioid adenocarcinoma and their prognostic significance.
Wei S; Conner MG; Zhang K; Siegal GP; Novak L
Int J Gynecol Pathol; 2010 Nov; 29(6):562-7. PubMed ID: 20881855
[TBL] [Abstract][Full Text] [Related]
9. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?
Boruta DM; Gehrig PA; Groben PA; Bae-Jump V; Boggess JF; Fowler WC; Van Le L
Cancer; 2004 Nov; 101(10):2214-21. PubMed ID: 15452833
[TBL] [Abstract][Full Text] [Related]
10. Age-specific survival of women with endometrioid adenocarcinoma of the uterus.
Farley JH; Nycum LR; Birrer MJ; Park RC; Taylor RR
Gynecol Oncol; 2000 Oct; 79(1):86-9. PubMed ID: 11006037
[TBL] [Abstract][Full Text] [Related]
11. Histopathological prognostic factors predicting para-aortic lymph node metastasis in patients with endometrioid uterine cancer.
Karube Y; Fujimoto T; Takahashi O; Nanjyo H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
Gynecol Oncol; 2010 Aug; 118(2):151-4. PubMed ID: 20621776
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma of the corpus uteri.
Creasman WT; Odicino F; Maisonneuve P; Beller U; Benedet JL; Heintz AP; Ngan HY; Sideri M; Pecorelli S
J Epidemiol Biostat; 2001; 6(1):47-86. PubMed ID: 11385776
[No Abstract] [Full Text] [Related]
13. [Prognostic factors uterine corpus cancer].
Inoue M
Gan To Kagaku Ryoho; 2006 Dec; 33(13):2008-13. PubMed ID: 17197744
[TBL] [Abstract][Full Text] [Related]
14. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
[TBL] [Abstract][Full Text] [Related]
15. Comorbid and clinical determinants of prognosis in endometrial cancer.
Wells CK; Stoller JK; Feinstein AR; Horwitz RI
Arch Intern Med; 1984 Oct; 144(10):2004-9. PubMed ID: 6385896
[TBL] [Abstract][Full Text] [Related]
16. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
17. Staging and assessing trophoblastic tumors. A possible solution to an intractable problem.
Kohorn EI
J Reprod Med; 1998 Jan; 43(1):33-6. PubMed ID: 9475147
[TBL] [Abstract][Full Text] [Related]
18. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the revised International Federation of Gynecology and obstetrics staging for early invasive squamous cervical cancer.
Takeshima N; Yanoh K; Tabata T; Nagai K; Hirai Y; Hasumi K
Gynecol Oncol; 1999 Aug; 74(2):165-9. PubMed ID: 10419727
[TBL] [Abstract][Full Text] [Related]
20. The CD44v6-negative phenotype in high-grade uterine carcinomas correlates with serous histologic subtype.
Soslow RA; Shen PU; Isacson C; Chung MH
Mod Pathol; 1998 Feb; 11(2):194-9. PubMed ID: 9504691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
